收藏切换
Comprehensive clinical evaluation of acetyl-levo-carnitine, epalrestat and mecobalamin in the treatment of diabetic peripheral neuropathy
收藏切换
Yuyan FU, Xiaoxiao QIN, Wendi CHENG, Haiyin WANG*
World Clinical Drug | 2022, 43(7) : 911 - 916
Less
收藏切换
World Clinical Drug | 2022, 43(7): 911-916
• Article •
Comprehensive clinical evaluation of acetyl-levo-carnitine, epalrestat and mecobalamin in the treatment of diabetic peripheral neuropathy
Full
Yuyan FU, Xiaoxiao QIN, Wendi CHENG, Haiyin WANG*
Affiliations
  • Shanghai Health Development Research Center, Shanghai 201199, China
Published: 2022-07-10 doi: 10.13683/j.wph.2022.07.017
Outline
收藏切换
Objective

To comprehensively analyze and evaluate the multi-dimensional value of acetyl-levo-carnitine, epalrestat and mecobalamin in the treatment of diabetic peripheral neuropathy (DPN), to provide a basis for clinical rational drug use.

Methods

The efficacy, safety, cost-effectiveness and innovation of acetyl-levo-carnitine, epalrestat and mecobalamin were comprehensively compared by literature review.

Results

In terms of efficacy, acetyl-levo-carnitine was significantly better than mecobalamin in the median sensory nerve conduction velocity, and it was better than that of mecobalamin in the improvement of pain symptoms. Other efficacy indicators of acetyl-levo-carnitine were similar to mecobalamin and epalrestat. In terms of safety, the incidence of adverse reactions or serious adverse events of acetyl-levo-carnitine, epalrestat and mecobalamin was similar, and all of them were mild adverse reactions. In terms of cost-effectiveness, acetyl-levo-carnitine is more cost-effective than epalrestat and mecobalamin. In terms of innovation, acetyl-levo-carnitine has the dual effects of improving cellular energy metabolism and analgesia in nerve cells.

Conclusion

acetyl-levo-carnitine, epalrestat and mecobalamin have little difference in efficacy and safety. In terms of economy and innovation, acetyl-levo-carnitine has higher value.

diabetic peripheral neuropathy  /  acetyl-levo-carnitine  /  epalrestat  /  mecobalamin  /  comprehensive clinical evaluation
符雨嫣, 覃肖潇, 程文迪, 王海银. 乙酰左卡尼汀、依帕司他及甲钴胺治疗糖尿病周围神经病变的临床综合评价. 世界临床药物, 2022 , 43 (7) : 911 -916 . DOI: 10.13683/j.wph.2022.07.017
Yuyan FU, Xiaoxiao QIN, Wendi CHENG, Haiyin WANG. Comprehensive clinical evaluation of acetyl-levo-carnitine, epalrestat and mecobalamin in the treatment of diabetic peripheral neuropathy[J]. World Clinical Drug, 2022 , 43 (7) : 911 -916 . DOI: 10.13683/j.wph.2022.07.017
Year 2022 volume 43 Issue 7
13
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.07.017
  • Receive Date:2022-03-11
  • Online Date:2026-11-19
  • Published:2022-07-10
Article Data
Affiliations
History
  • Received:2022-03-11
Affiliations
    Shanghai Health Development Research Center, Shanghai 201199, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.017
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT